Stock Screener App

Gratuito -

Installare

43.00

5.49% -2.50

after-market

Dopo l'orario di chiusura: 43.10 0.10 +0.23%

Soleno Therapeutics Inc (SLNO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie

SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP - GlobeNewswire

Soleno Therapeutics (SLNO) Among Stocks That Will Bounce Back According to Analysts - Insider Monkey

Why Soleno Therapeutics Inc. stock is popular among millennialsWeekly Investment Report & Safe Entry Momentum Stock Tips - ulpravda.ru

Assessing Soleno Therapeutics (SLNO) Valuation After JCEM VYKAT XR Data And FDA Approval - Yahoo Finance

Macro Review: Can Soleno Therapeutics Inc. stock hit record highs againJuly 2025 Short Interest & Expert Curated Trade Setups - ulpravda.ru

Can Soleno Therapeutics Inc. stock hit record highs again2025 Major Catalysts & Smart Investment Allocation Tips - ulpravda.ru

Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the ... - Bluefield Daily Telegraph

Star Tribune - FinancialContent

12 Stocks that Will Bounce Back According to Wall Street Analysts - Insider Monkey

Will Soleno Therapeutics Inc. stock deliver strong dividend growthQuarterly Profit Review & Expert Curated Trade Setup Alerts - ulpravda.ru

What technical signals suggest for Soleno Therapeutics Inc. stockOil Prices & Weekly Setup with ROI Potential - ulpravda.ru

Does Soleno Therapeutics Inc. stock trade at a discount to peersWeekly Stock Report & Weekly High Return Opportunities - ulpravda.ru

Soleno Therapeutics announces entry into $100M accelerated share repurchase agreement - MSN

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance

Is Soleno Therapeutics Inc. stock supported by strong fundamentalsEconomic Data Impact & Market-Leading Growth Rates - ulpravda.ru

Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123 - MSN

Soleno’s PWS treatment study results published in endocrinology journal By Investing.com - Investing.com Nigeria

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno ... - Bluefield Daily Telegraph

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - FinancialContent

Do You Believe in the Growth Prospects of Soleno Therapeutics (SLNO)? - Insider Monkey

A Look At Soleno Therapeutics (SLNO) Valuation After Pivotal VYKAT XR Study Publication And FDA Approval - Sahm

Soleno’s PWS treatment study results published in endocrinology journal - Investing.com

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Unraveling The 140% Upside Potential - DirectorsTalk Interviews

Soleno Therapeutics Announces Publication of Positive Study Results for VYKAT XR in Journal of Clinical Endocrinology and Metabolism - Quiver Quantitative

New PWS hunger drug shows symptoms worsen off treatment in key study - Stock Titan

Allspring Global Investments Holdings LLC Buys 201,983 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat

Soleno Therapeutics, Inc. $SLNO Stake Cut by Voya Investment Management LLC - MarketBeat

SLNO News Today | Why did Soleno Therapeutics stock go up today? - MarketBeat

Understanding Momentum Shifts in (SLNO) - Stock Traders Daily

Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Risk Hedge: Why analysts recommend Soleno Therapeutics Inc 6XC stock2025 Trading Volume Trends & Community Consensus Trade Alerts - moha.gov.vn

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO) - Business Wire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Shareholders to Connect - ACCESS Newswire

Soleno Therapeutics stock slides today: SLNO drops on investor-alert headline as biotech sector slips - ts2.tech

2025-12-29 | Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | NDAQ:SLNO | Press Release - Stockhouse

Soleno Therapeutics, Inc. $SLNO Stake Lessened by Harbor Capital Advisors Inc. - MarketBeat

Market Sentiment Around Loss-Making Soleno Therapeutics, Inc. (NASDAQ:SLNO) - 富途牛牛

Soleno Therapeutics Shares Dip Following $200 Million Stock Offering Pricing - MSN

Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects - MSN

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

2025-12-28 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Learn More About the Investigation | NDAQ:SLNO | Press Release - Stockhouse

Soleno Therapeutics Earnings Notes - Trefis

Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Is Soleno Therapeutics Inc. stock affected by interest rate hikesMarket Sentiment Report & Free High Margin Investment Plays - bollywoodhelpline.com

Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Connect - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

2025-12-24 | Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | NDAQ:SLNO | Press Release - Stockhouse

Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Soleno Therapeutics (NASDAQ:SLNO) Share Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat

Precision Trading with Soleno Therapeutics Inc. (SLNO) Risk Zones - Stock Traders Daily

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation - ACCESS Newswire

Is Soleno Therapeutics (NASDAQ:SLNO) Using Debt Sensibly? - 富途牛牛

Fed Meeting: What momentum indicators show for Soleno Therapeutics Inc. stock2025 Market WrapUp & Weekly Return Optimization Alerts - Улправда

Will Soleno Therapeutics Inc. stock see insider buyingQuarterly Portfolio Report & Accurate Entry/Exit Alerts - Улправда

Why Soleno Therapeutics Inc. stock could rally in 2025Dollar Strength & Weekly Top Stock Performers List - Улправда

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Reach Out - ACCESS Newswire

How Soleno Therapeutics Inc. stock performs in weak economyPortfolio Risk Report & Low Drawdown Momentum Trade Ideas - Улправда

Rate Hike: What momentum indicators show for Soleno Therapeutics Inc. stockJuly 2025 Technicals & Community Verified Trade Signals - ulpravda.ru

INCY

$106.87

0.90%

GMAB

$34.26

1.87%

RVMD

$118.64

10.48%

BNTX

$99.85

1.01%

ONC

$337.89

5.47%

INSM

$175.97

3.35%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters